Endra Life Sciences Inc (NDRA)
4.20 x 1 4.29 x 1
Post-market by (Cboe BZX)
4.30 +0.32 (+8.04%) 04/28/25 [NASDAQ]
4.20 x 1 4.29 x 1
Post-market 4.20 -0.10 (-2.33%) 19:19 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | NDRA | VERO | BJDX | ||
Company | Endra Life Sciences Inc | Venus Concept Inc | Bluejay Diagnostics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 3.85 | 2.49 | 1.6800 | ||
High | 4.33 | 2.55 | 1.8500 | ||
Low | 3.46 | 2.40 | 1.6300 | ||
Last | 4.30 | 2.51 | 1.7000 | ||
Change | +0.32 | +0.03 | +0.0300 | ||
% Change | +8.04% | +1.21% | +1.80% | ||
Volume | 249,500 | 89,200 | 308,400 | ||
20-Day Average Volume | 369,885 | 3,553,275 | 3,451,570 | ||
Previous Close | 3.98 | 2.48 | 1.6700 | ||
Industry | Medical Instruments | Medical Instruments | Medical Instruments | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 3.80 | 3.23 | 2.7470 | ||
20-Day Raw Stochastic | 41.82% | 2.84% | 2.75% | ||
20-Day Relative Strength | 52.26% | 46.48% | 40.33% | ||
Weighted Alpha | -86.87 | -82.07 | -95.38 | ||
Today's Opinion | 72% Sell | 88% Sell | 100% Sell | ||
Previous Opinion | 88% Sell | 96% Sell | 100% Sell | ||
Last Month's Opinion | 88% Sell | 72% Sell | 40% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +27.98% since 04/21/25 | -7.38% since 04/21/25 | -0.58% since 04/21/25 | ||
Low | 2.97 on 04/22/25 | 2.39 on 04/25/25 | 1.4600 on 04/24/25 | ||
High | 4.33 on 04/28/25 | 2.80 on 04/23/25 | 1.8500 on 04/28/25 | ||
1-Month | |||||
%Chg | +6.18% since 03/28/25 | -8.73% since 03/28/25 | -55.38% since 03/28/25 | ||
Low | 2.97 on 04/22/25 | 2.16 on 04/04/25 | 1.4600 on 04/24/25 | ||
High | 6.15 on 04/07/25 | 14.50 on 04/09/25 | 10.2000 on 04/07/25 | ||
3-Month | |||||
%Chg | -14.00% since 01/28/25 | -29.88% since 01/28/25 | -57.07% since 01/28/25 | ||
Low | 2.97 on 04/22/25 | 2.16 on 04/04/25 | 1.4600 on 04/24/25 | ||
High | 6.15 on 04/07/25 | 14.50 on 04/09/25 | 10.2000 on 04/07/25 | ||
6-Month | |||||
%Chg | -55.82% since 10/28/24 | -46.93% since 10/28/24 | -67.89% since 10/28/24 | ||
Low | 2.97 on 04/22/25 | 2.16 on 04/04/25 | 1.4600 on 04/24/25 | ||
High | 12.49 on 10/29/24 | 14.50 on 04/09/25 | 12.4500 on 11/05/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,990 | 3,362 | 1,956 | ||
Shares Outstanding, K | 562 | 1,424 | 554 | ||
Annual Sales | 0 | 64,830,000 | 0 | ||
Annual Net Income | -11,510,000 | -47,000,000 | -7,720,000 | ||
Last Quarter Sales | 0 | 15,770,000 | 0 | ||
Last Quarter Net Income | -4,150,000 | -7,970,000 | -1,430,000 | ||
60-Month Beta | 0.19 | 0.25 | 0.35 | ||
Per-Share Information | |||||
Most Recent Earnings | -9.40 on 03/31/25 | -11.23 on 03/31/25 | -112.37 on 03/31/25 | ||
Latest Earnings Date | 05/13/25 | 05/15/25 | 05/21/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |